increased sensitivity to induced morbidity/mortality_Cpa3<tm2Hrr>/Cpa3<tm2Hrr>

http://metadb.riken.jp/0009763I129P2OlaHsdCpa3tm2HrrCpa3tm2HrrCpa3tm2Hrr

increased sensitivity to induced morbidity/mortality_Cpa3<tm2Hrr>/Cpa3<tm2Hrr>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• carboxypeptidase A3, mast cell
  http://metadb.riken.jp/db/mgi_rdf/MGI:88479

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Cpa3<tm2Hrr>/Cpa3<tm2Hrr>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Cpa3<tm2Hrr>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased sensitivity to induced morbidity/mortality
  http://purl.obolibrary.org/obo/MP_0009763

文献

http://purl.org/net/cito/citesAsAuthority

• Lars A. Schneider, et.al., Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin., The Journal of experimental medicine, 2007, 204
  http://rdf.ncbi.nlm.nih.gov/pubmed/17923505